Search results for " tests"

showing 10 items of 3284 documents

Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells

1987

We have investigated the capacity of the encephalitogenic BS rat T cell line bs 83 and its variant clone bs 83.III.C6 to synthesize and express RT1.B-specific class II molecule subsets defined by monoclonal antibodies (mAb) MRC-OX6 and MRC-OX3. Earlier studies had indicated that mAb MRC-OX6 recognizes three distinct molecular species: an immature oligomeric polypeptide chain complex comprised of the polymorphic subunits alpha, beta and the invariant proteins of the gamma group; a biosynthetic intermediate composed of post-translationally modified alpha, beta and gamma chain (denoted p35) and a fully glycosylated alpha, beta two-chain complex derived from the plasma membrane. MRC-OX3 was sho…

Time Factorsmedicine.drug_classT-LymphocytesT cellImmunologyAlpha (ethology)Cell SeparationBiologyMonoclonal antibodyEpitopeCell LineIodine RadioisotopesEpitopesAntigenmedicineAnimalsImmunology and AllergyBeta (finance)Polymorphism GeneticHistocompatibility Antigens Class IIMyelin Basic ProteinRats Inbred StrainsPrecipitin TestsRatsCell biologyPhenotypemedicine.anatomical_structureRats Inbred LewCell cultureMutationImmunologyImmunizationClone (B-cell biology)Immunoelectrophoresis Two-DimensionalEuropean Journal of Immunology
researchProduct

Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial

2014

Background: The integrated treatment of first episode psychosis has been shown to improve functionality and negative symptoms in previous studies. In this paper, we describe a study of integrated treatment (individual psychoeducation complementary to pharmacotherapy) versus treatment as usual, comparing results at baseline with those at 6-month re-assessment (at the end of the study) for these patients, and online training of professionals to provide this complementary treatment, with the following objectives: 1) to compare the efficacy of individual psychoeducation as add-on treatment versus treatment as usual in improving psychotic and mood symptoms; 2) to compare adherence to medication,…

Time Factorsmedicine.medical_treatmentGlobal Assessment of FunctioningMedicine (miscellaneous)Liebowitz social anxiety scaleWeb-based instructionlaw.inventionStudy Protocolmulticenter trialClinical ProtocolsRandomized controlled triallawSurveys and QuestionnairesSingle-Blind MethodPharmacology (medical)PHARMACOLOGY (MEDICAL)validationPositive and Negative Syndrome ScaleCombined Modality TherapyTreatment OutcomeResearch Designspanish versionAprenentatge electrònicAnxietymedicine.symptomAntipsychotic Agentsmedicine.medical_specialtyPsicosiMedication Adherencescale1st-episode psychosisPredictive Value of TestsPsychoeducationmedicineHumansSocial BehaviorPsychiatryPsychiatric Status Rating ScalesInternetbusiness.industryMEDICINEBrain-Derived Neurotrophic FactorHamilton Rating Scale for DepressionPsychoses5-year follow-upstandard treatementPsychotherapyAffectLogistic ModelsMoodPsychotic Disordersopus trialSpainquality-of-lifeLinear ModelsQuality of Lifebusinesscognitive-behavior therapyBiomarkersComputer-Assisted InstructionTrials
researchProduct

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxin

2005

Zearalenone (ZEA) is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. It is frequently implicated in reproductive disorders of farm animals and occasionally in hyperoestrogenic syndromes in humans. There is evidence that ZEA and its metabolites possess oestrogenic activity in pigs, cattle and sheep. However, ZEA is of a relatively low acute toxicity after oral or interperitoneal administration in mice, rat and pig. The biotransformation for ZEA in animals involves the formation of two metabolites alpha-zearalenol (alpha-ZEA) and beta-zearalenol (beta-ZEA) which are subsequently conjugated with glucuronic acid. Moreover, ZEA has also been shown to be h…

Tolerable daily intakeAnimal feedDevelopmental toxicityBiologyGlobal HealthToxicologyToxicologyEatingchemistry.chemical_compoundToxicity TestsAnimalsHumansEstrogens Non-SteroidalMycotoxinZearalenoneChronic toxicityTraditional medicinefungiMycotoxicosisfood and beveragesGeneral MedicineAnimal FeedAcute toxicitychemistryInactivation MetabolicToxicityFood MicrobiologyZearalenoneFood ScienceFood and Chemical Toxicology
researchProduct

Metabolic mapping with bioluminescence: basic and clinical relevance

2002

This review is focused on metabolic mapping in biological tissue with quantitative bioluminescence and single photon imaging. Metabolites, such as ATP, glucose and lactate, can be imaged quantitatively and within microscopic dimensions in cryosections from shock frozen biological specimens using enzyme reactions and light emission by luciferases. The technique has been applied in numerous targets and models of experimental biomedical research, such as multicellular spheroids, various organs of laboratory animals in a physiological or pathophysiological state, and even in plant seeds. Among numerous other aspects, data obtained with this method have contributed to the elucidation of mechanis…

Tomography Emission-Computed Single-PhotonPathologymedicine.medical_specialtyCellBioengineeringIn situ hybridizationBiologymedicine.diseaseMalignancyMetastasismedicine.anatomical_structurePredictive Value of TestsNeoplasmsLuminescent MeasurementsImmunologyBiomarkers TumormedicineHumansBioluminescence imagingBioluminescenceImmunohistochemistryLight emissionMolecular BiologyBiotechnologyBiomolecular Engineering
researchProduct

Precision electroweak measurements on the Z resonance

2005

We report on the final electroweak measurements performed with data taken at the Z resonance by the experiments operating at the electron-positron colliders SLC and LEP. The data consist of 17 million Z decays accumulated by the ALEPH, DELPHI, L3 and OPAL experiments at LEP, and 600 thousand Z decays by the SLD experiment using a polarised beam at SLC. The measurements include cross-sections, forward-backward asymmetries and polarised asymmetries. The mass and width of the Z boson, $\MZ$ and $\GZ$, and its couplings to fermions, for example the $\rho$ parameter and the effective electroweak mixing angle, are precisely measured. The number of light neutrino species is determined to be 2.9840…

Top quarkFORWARD-BACKWARD ASYMMETRYPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; ALEPH; DELPHI; L3; OPALGeneral Physics and Astronomy01 natural sciences7. Clean energyHigh Energy Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)electron-positron physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Electroweak interactionPhysicsQuantum chromodynamicsOPALElectron–positron physics; Electroweak interactions; Decays of heavy intermediate gauge bosons; Fermion–antifermion production; Precision measurements at the Z resonance; Tests of the Standard Model; Radiative corrections; Effective coupling constants; Neutral weak current; Z boson; W boson; Top quark; Higgs bosonParticle physics - ExperimentPhysicsSettore FIS/01 - Fisica SperimentaleElectroweak interactionFORWARD-BACKWARD ASYMMETRY; FERMION-PAIR PRODUCTION; HADRONIC-Z-DECAYS; TOP-QUARK MASS; ANGLE BHABHA SCATTERING; W-BOSON MASS; CROSS-SECTION ASYMMETRY; Z-LINE-SHAPE; SEMILEPTONIC BRANCHING RATIOS; CARLO EVENT GENERATORdecays of heavy intermediate gauge bosons; effective coupling constants; electron-positron physics; electroweak interactions; fermion-antifermion production; higgs boson; neutral weak current; precision measurements at the z resonance; radiative corrections; tests of the standard model; top quark; w boson; z bosonRadiative correctionsALEPHLARGE ELECTRON POSITRON COLLIDERRadiative correctionHigh Energy Physics - PhenomenologyFIS/01 - FISICA SPERIMENTALEDecays of heavy intermediate gauge bosonsL3Z-LINE-SHAPEHiggs bosonFERMION-PAIR PRODUCTIONPARTICLE PHYSICSFísica nuclearNeutrinoFermion–antifermion productionPrecision measurements at the Z resonanceTests of the Standard ModelParticle physicsZ bosonfermion-antifermion productionElectroweak interactionsHiggs bosonFOS: Physical sciencesddc:500.2Elementary particle physics ; z boson ; LEP ; electroweakDecays of heavy intermediate gauge bosonEffective coupling constantPartícules (Física nuclear)Standard ModelNeutral weak currentelectroweak theory Z boson DELPHI ALEPH OPAL L30103 physical sciencesANGLE BHABHA SCATTERINGCROSS-SECTION ASYMMETRYSEMILEPTONIC BRANCHING RATIOS010306 general physicsTOP-QUARK MASSEffective coupling constantsDELPHICoupling constantElectron–positron physics010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFermionCARLO EVENT GENERATORTop quarkW-BOSON MASSFORWARD-BACKWARD ASYMMETRY FERMION-PAIR PRODUCTION HADRONIC-Z-DECAYS TOP-QUARK MASS ANGLE BHABHA SCATTERING W-BOSON MASS CROSS-SECTION ASYMMETRY Z-LINE-SHAPE SEMILEPTONIC BRANCHING RATIOS CARLO EVENT GENERATOR[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]Experimental High Energy PhysicsElectron–positron physicW bosonHigh Energy Physics::ExperimentFIS/04 - FISICA NUCLEARE E SUBNUCLEAREHADRONIC-Z-DECAYSPHYSICS REPORTS-REVIEW SECTION OF PHYSICS LETTERS
researchProduct

Electroweak measurements in electron-positron collisions at W-boson-pair energies at LEP

2013

The ALEPH, DELPHI, L3, OPAL collaborations and LEP Electroweak Working Group.-- arXiv:1302.3415

Top quarkPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; ALEPH; DELPHI; L3; OPALElectron–positron annihilationPrecision measurements at W-pair energiesWW bosonGeneral Physics and AstronomyCOLOR DIPOLE MODEL01 natural sciences7. Clean energyZZ bosonMathematical SciencesHigh Energy Physics - Experimentelectroweak interactionsHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)electron-positron physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]FERMION-LOOP SCHEMEANOMALOUS MAGNETIC-MOMENTOF-MASS ENERGIES; TOP-QUARK MASS; CARLO EVENT GENERATOR; HADRONIC Z-DECAYS; INVARIANT YFS EXPONENTIATION; ANOMALOUS MAGNETIC-MOMENT; (UN)STABLE W+W-PRODUCTION; FERMION-LOOP SCHEME; COLOR DIPOLE MODEL; LEADING ORDER QCDeffective coupling constantsBosonPhysicsOPALPhysicsElectroweak interactionSettore FIS/01 - Fisica Sperimentalehep-phPrecision measurements at WW-pair energiesRadiative correctionsALEPHNuclear & Particles PhysicsLARGE ELECTRON POSITRON COLLIDER3. Good healthRadiative correctionHigh Energy Physics - PhenomenologyOF-MASS ENERGIESDecays of heavy intermediate gauge bosonsINVARIANT YFS EXPONENTIATIONPrecision measurements at W-pair energieFermion-antifermion productionL3Physical SciencesComputingMethodologies_DOCUMENTANDTEXTPROCESSINGPARTICLE PHYSICSFísica nuclearProduction (computer science)decays of heavy intermediate gauge bosons; neutral weak current; w boson; tests of the standard model; precision measurements at w-pair energies; fermion-antifermion production; top quark; electron-positron physics; electroweak interactions; effective coupling constants; higgs boson; z boson; radiative correctionsFermion–antifermion productionELECTROWEAK INTERACTIONTests of the Standard ModelParticle Physics - ExperimentParticle physicsZ bosonElectron-positron physicElectroweak interactionsLEADING ORDER QCDHiggs boson(UN)STABLE W+W-PRODUCTIONFOS: Physical sciencesdecays of heavy intermediate gauge bosonsddc:500.2Decays of heavy intermediate gauge bosonEffective coupling constantPartícules (Física nuclear)Standard ModelNuclear physicsPhysics and Astronomy (all)Neutral weak current0103 physical sciencesddc:530010306 general physicsTOP-QUARK MASSEffective coupling constantsDELPHIElectron–positron physicshep-ex010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyCARLO EVENT GENERATORTop quarkradiative correctionsElectron-positron physics; Electroweak interactions; Decays of heavy intermediate gauge bosons; Fermion-antifermion production; Precision measurements at W-pair energies; Tests of the Standard Model; Radiative corrections; Effective coupling constants; Neutral weak current; Z boson; W boson; Top quark; Higgs bosonHADRONIC Z-DECAYSCol·lisions (Física nuclear)[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]Experimental High Energy PhysicsLarge Electron–Positron ColliderW bosonHigh Energy Physics::ExperimentElectron-positron physics
researchProduct

Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro

1992

It has been observed that Ito cells in vitro undergo phenotypical changes ("activation") similar to those noted in vivo during the development of liver fibrosis. Because conflicting data have been published on the amount and different types of collagens synthesized by Ito cells in vitro, collagen biosynthesis was studied at different "activation" stages on both the protein and RNA levels. Immunoprecipitation of endogenously labeled collagen showed that freshly isolated ("resting") Ito cells synthesize mainly collagen type IV. Collagen type I was hardly detectable in the earlier stage of primary culture, but it clearly increased starting 5 days after isolation. Compared with the basal rates …

Transcription GeneticMolecular Sequence DataCell SeparationBiologychemistry.chemical_compoundBiosynthesisIn vivomedicineAnimalsCells CulturedBasement membraneBase SequenceHepatologyGastroenterologyRNARats Inbred StrainsImmunohistochemistryPrecipitin TestsMolecular biologyIn vitroRatsmedicine.anatomical_structureAdipose TissueBiochemistrychemistryCell cultureHepatic stellate cellRNAImmunohistochemistryElectrophoresis Polyacrylamide GelFemaleCollagenGastroenterology
researchProduct

Destabilized green fluorescent protein detects rapid removal of transcription blocks after genotoxic exposure

2007

High stabilities of reporter proteins and their messenger RNAs (mRNAs) interfere with the detection of rapid transient changes in gene expression, such as transcriptional blocks posed by genotoxic DNA lesions. We have modified a green fluorescent protein (GFP) gene within the episomal pMARS vector by addition of a fragment encoding for mouse ornithine decarboxylase (ODC) proline-glutamate-serine-threonine-rich (PEST) sequence in order to target the protein to the proteasomes and achieved an unprecedentedly fast GFP turnover in permanently transfected human cells. As early as 1 h after inhibition of protein synthesis by cycloheximide, the number of fluorescent cells decreased more than 5-fo…

Transcription GeneticMutagenicity TestsUltraviolet RaysDNA repairGreen Fluorescent ProteinsfungiCycloheximideBiologyMolecular biologyGeneral Biochemistry Genetics and Molecular BiologyGreen fluorescent proteinchemistry.chemical_compoundSpectrometry FluorescencechemistryTranscription (biology)Gene expressionProtein biosynthesisHumansGeneMicronuclei Chromosome-DefectiveDNADNA DamageHeLa CellsBiotechnologyBioTechniques
researchProduct

Congenital hypothyroidism: A 2020-2021 consensus guidelines update-An ENDO-European Reference Network initiative endorsed by the European Society for…

2021

Background: An ENDO-European Reference Network (ERN) initiative was launched that was endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology with 22 participants from the ENDO-ERN and the two societies. The aim was to update the practice guidelines for the diagnosis and management of congenital hypothyroidism (CH). A systematic literature search was conducted to identify key articles on neonatal screening, diagnosis, and management of primary and central CH. The evidence-based guidelines were graded with the Grading of Recommendations, Assessment, Development and Evaluation system, describing both the strength of recommendations and the quali…

Transition to Adult Caremedicine.medical_specialtyConsensusdyshormonogenesisPediatric endocrinologyEndocrinology Diabetes and MetabolismLevothyroxine030209 endocrinology & metabolismHarmonization03 medical and health sciences0302 clinical medicineEndocrinologyNeonatal ScreeningPredictive Value of TestsRisk FactorsInternal medicineEpidemiologyCentral hypothyroidismneonatal screeningHumansMedicineguidelinesGrading (education)thyroid dysgenesisCongenital hypothyroidism guidelines pediatric endocrinologycongenital hypothyroifidm consensus guideline EndoERNEvidence-Based Medicinebusiness.industryInfant Newborncentral hypothyroidismcongenital hypothyroidismPrognosismedicine.diseaseCongenital hypothyroidismBenchmarkingEndocrinology030220 oncology & carcinogenesisFamily medicineEtiologySpecial Articlesbusinessmedicine.drugYearbook of Paediatric Endocrinology
researchProduct

Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent a…

2010

Artemisia annua L. (sweet wormwood, qinhao) has traditionally been used in Chinese medicine. The isolation of artemisinin from Artemisia annua and its worldwide accepted application in malaria therapy is one of the showcase success stories of phytomedicine during the past decades. Artemisinin-type compounds are also active towards other protozoal or viral diseases as well as cancer cells in vitro and in vivo. Nowadays, Artemisia annua tea is used as a self-reliant treatment in developing countries. The unsupervised use of Artemisia annua tea has been criticized to foster the development of artemisinin resistance in malaria and cancer due to insufficient artemisinin amounts in the plant as c…

Trypanosoma brucei bruceiArtemisia annuaPharmaceutical ScienceArtemisia annuaPharmacologyHeLachemistry.chemical_compoundPhytomedicineParasitic Sensitivity TestsScopoletinparasitic diseasesDrug DiscoverymedicineHumansArtemisininOligonucleotide Array Sequence AnalysisPharmacologyScopoletinEucalyptolDose-Response Relationship DrugMolecular StructurebiologyPlant Extractsfood and beveragesCyclohexanolsbiology.organism_classificationAntineoplastic Agents PhytogenicTrypanocidal AgentsArtemisininsBioactive compoundEucalyptolComplementary and alternative medicinechemistryDrug Resistance NeoplasmCancer cellMonoterpenesMolecular MedicineDrug Screening Assays AntitumorHeLa Cellsmedicine.drugPhytomedicine
researchProduct